Special Issue on Drug and Disease Management
In
pharmacology, a drug a chemical substance that is used to treat, cure, prevent,
or diagnose a disease or to promote our health. The goal of this special issue
is to provide a platform for scientists and academicians all over the world to
promote, share, and discuss various new issues and developments in the area of Drug
and Disease Management.
In this special issue, we intend to invite
front-line researchers and authors to submit original research and review
articles on exploring Drug and Disease Management. Potential topics include, but are not limited to:
-
Acetaminophen
-
Antihypertensive
-
Atorvastatin
-
Ciprofloxacin
-
Doxycycline
-
Ibuprofen
-
Melatonin
-
Metformin
-
Methotrexate
-
Naloxone
-
Tramadol
-
Pharmaceutical drugs
-
Pharmacokinetics
-
Psychoactive drugs
-
Cardiovascular drugs
-
Drug abuse
-
Clinical drug evaluation
-
Drug analysis and drug discovery
Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic
copy of their complete manuscript through the journal’s Paper Submission
System.
Please kindly specify the “Special Issue”
under your manuscript title. The research field “Special Issue - Drug
and Disease Management” should be selected during your submission.
Special Issue Timetable:
Submission Deadline
|
March 31st, 2025
|
Publication Date
|
May 2025
|
Guest Editor:
Dr. Marjan Dzeparoski
Associate
Professor, Faculty for Medical Sciences, Stip, Macedonia
Member,
Pharmaceutical Chamber of R. Macedonia, Athens Institute for Education &
Research and European Federation of Biotechnology (EFB), Macedonia
For
further questions or inquiries, please contact Editorial Assistant at jbm@scirp.org.